Experimental infection of macaques with a wild water bird-derived highly pathogenic avian influenza virus (H5N1)

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Fujiyuki, Tomoko ^a   Yoneda, Misako ^a   Yasui, Fumihiko ^b   Kuraishi, Takeshi ^a   Hattori, Shosaku ^a   Kwon, Hyun Jeong ^a   Munekata, Keisuke ^b   Kiso, Yuri ^a   Kida, Hiroshi ^c   Kohara, Michinori ^b   Kai, Chieko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DISEASE MODEL; DISEASE SEVERITY; DISEASE TRANSMISSION; EXPERIMENTAL INFECTION; INFLUENZA A (H5N1); INOCULATION; JAPAN; LOWER RESPIRATORY TRACT INFECTION; MACACA; MACACA FASCICULARIS; NONHUMAN; RHESUS MONKEY; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE; WATER BIRD; WILD SPECIES;

ANIMALS; BIRDS; DISEASE MODELS, ANIMAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; MACACA MULATTA; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84893176543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083551     Document Type: Article

References (26)

1. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF et al. (1998) Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351: 472-477. doi:10.1016/S0140-6736(97)11212-0. PubMed: 9482438. (Pubitemid 28070093)
2. Subbarao K, Klimov A, Katz J, Regnery H, Lim W et al. (1998) Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279: 393-396. doi:10.1126/science.279. 5349.393. PubMed: 9430591. (Pubitemid 28063376)
3. Kida H, Sakoda Y (2006) Library of influenza virus strains for vaccine and diagnostic use against highly pathogenic avian influenza and human pandemics. Dev Biol (Basel) 124: 69-72. PubMed: 16447496. (Pubitemid 43258901)
4. Chen Y, Deng W, Jia C, Dai X, Zhu H et al. (2009) Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch Virol 154: 227-233. doi:10.1007/s00705-008-0277-5. PubMed: 19130169.
5. Fan S, Gao Y, Shinya K, Li CK, Li Y et al. (2009) Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog 5: e1000409. PubMed: 19412338.
6. Okamatsu M, Tanaka T, Yamamoto N, Sakoda Y, Sasaki T et al. (2010) Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes 41: 351-357. doi:10.1007/s11262-010-0530- 3. PubMed: 20848174.
7. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M (2007) Transmission of influenza A in human beings. Lancet Infect Dis 7: 257-265. doi:10.1016/S1473-3099(07)70029-4. PubMed: 17376383. (Pubitemid 46414066)
8. Tellier R (2006) Review of aerosol transmission of influenza A virus. Emerg Infect Dis 12: 1657-1662. doi:10.3201/eid1211.060426. PubMed: 17283614.
9. Cillóniz C, Shinya K, Peng X, Korth MJ, Proll SC et al. (2009) Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 5: e1000604. PubMed: 19798428.
10. Itoh Y, Ozaki H, Tsuchiya H, Okamoto K, Torii R et al. (2008) A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26: 562-572. doi:10.1016/j.vaccine.2007.11.031. PubMed: 18164788.
11. Kreijtz JH, Suezer Y, de Mutsert G, van den Brand JM, van Amerongen G et al. (2009) Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. J Infect Dis 199: 405-413. doi:10.1086/595984. PubMed: 19061423.
12. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA et al. (2001) Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 75: 6687-6691. doi:10.1128/JVI.75.14.6687-6691.2001. PubMed: 11413336. (Pubitemid 32578188)
13. Wheeldon EB, Walker ME, Murphy DJ, Turner CR (1992) Intratracheal aerosolization of endotoxin in the rat: a model of the adult respiratory distress syndrome (ARDS). Lab Anim 26: 29-37. doi:10.1258/002367792780809020. PubMed: 1548844.
14. Williams PD, Tyrrell DJ, Storm NE, Holme KR (1997) Use of a precise intratracheal delivery system to compare the acute tolerance of heparin and the heparinoid GM2000 in rabbits. Toxicology Methods 7: 1-7. doi:10.1080/ 105172397243268.
15. Sakurai A, Nomura N, Nanba R, Sinkai T, Iwaki T et al. (2011) Rapid typing of influenza viruses using super high-speed quantitative real-time PCR. J Virol Methods 178: 75-81. doi:10.1016/j.jviromet.2011.08.015. PubMed: 21889540.
16. Gao P, Watanabe S, Ito T, Goto H, Wells K et al. (1999) Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 73: 3184-3189. PubMed: 10074171. (Pubitemid 29135710)
17. Suzuki E, Ichihara K (2008) The course of fever following influenza virus infection in children treated with oseltamivir. J Med Virol 80: 1065-71. PubMed: 18428131. (Pubitemid 351657020)
18. Berendt RF (1974) Simian model for the evaluation of immunity to influenza. Infect Immun 9: 101-105. PubMed: 4202882.
19. Saslaw S, Wilson HE, Doan CA, Woolpert OC, Schwab JL (1946) Reactions of monkeys to experimentally induced influenza virus A infection; an analysis of the relative rôles of humoral and cellular immunity under conditions of optimal or deficient nutrition. J Exp Med 84: 113-125. doi:10.1084/jem.84.2.113. PubMed: 20994377.
20. Gao R, Dong L, Dong J, Wen L, Zhang Y et al. (2010) A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLOS ONE 5: e13315. doi:10.1371/journal.pone.0013315. PubMed: 20976271.
21. Sirinonthanawech N, Uiprasertkul M, Suptawiwat O, Auewarakul P (2011) Viral load of the highly pathogenic avian influenza H5N1 virus in infected human tissues. J Med Virol 83: 1418-1423. doi:10.1002/jmv.22146. PubMed: 21678447.
22. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207. doi:10.1038/nm1477. PubMed: 16964257. (Pubitemid 44527358)
23. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ et al. (2009) Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 48: 1639-1649. doi:10.1086/599031. PubMed: 19435433.
24. Yu H, Gao Z, Feng Z, Shu Y, Xiang N et al. (2008) Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLOS ONE, 3: e2985. PubMed: 18716658.
25. Qureshi NR, Hien TT, Farrar J, Gleeson FV (2006) The radiologic manifestations of H5N1 avian influenza. J Thorac Imaging 21: 259-264. doi:10.1097/01.rti.0000213573.94032.53. PubMed: 17110849.
26. Kono K, Song H, Shingai Y, Shioda T, Nakayama EE (2008) Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology 373: 447-456. doi:10.1016/j.virol.2007.12.022. PubMed: 18201746.